DGLRX | RNPHX | DGLRX / RNPHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 9 years | - |
Gain YTD | 4.723 | 4.736 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 919M | 147B | 1% |
Annual Yield % from dividends | 0.37 | 1.00 | 37% |
Returns for 1 year | 2.39 | 16.66 | 14% |
Returns for 3 years | -15.95 | 8.08 | -197% |
Returns for 5 years | -3.12 | 40.30 | -8% |
Returns for 10 years | 20.40 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 23.27 | 0.33 | +1.44% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
FEZ | 52.59 | 0.55 | +1.06% |
SPDR® EURO STOXX 50 ETF | |||
XOMO | 14.44 | 0.06 | +0.42% |
YieldMax XOM Option Income Strategy ETF | |||
XSW | 194.62 | 0.70 | +0.36% |
SPDR® S&P Software & Services ETF | |||
XJUN | 39.16 | 0.05 | +0.12% |
FT Vest US Eq Enh&Mod Bffr ETF June |